Rocket Pharmaceuticals, Inc.
RCKT
$3.47
$0.133.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.25M | -209.38M | -223.12M | -240.91M | -257.30M |
| Total Depreciation and Amortization | 9.71M | 10.18M | 11.03M | 11.17M | 10.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -150.50M | 29.56M | 30.35M | 34.93M | 36.06M |
| Change in Net Operating Assets | -12.23M | -9.98M | -8.26M | -7.30M | 7.12M |
| Cash from Operations | -170.27M | -179.62M | -190.01M | -202.12M | -203.80M |
| Capital Expenditure | -127.00K | -169.00K | -440.00K | -669.00K | -2.31M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 361.98M | 179.42M | 104.21M | 30.14M | 17.09M |
| Cash from Investing | 361.85M | 179.25M | 103.77M | 29.47M | 14.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.00K | -1.00K | -- | -- | -- |
| Issuance of Common Stock | 152.00K | -- | -- | 182.85M | 183.03M |
| Repurchase of Common Stock | -67.00K | -67.00K | -67.00K | -67.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 215.00K | 215.00K | 215.00K | 215.00K |
| Cash from Financing | 82.00K | 147.00K | 148.00K | 183.00M | 183.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 191.66M | -221.00K | -86.10M | 10.35M | -5.79M |